DBV Technologies (DBVT) Common Equity (2015 - 2026)

DBV Technologies (DBVT) reported Common Equity of $207.9 million for Q1 2026, up 7068.97% year-over-year from $2.9 million in Q1 2025, and up 23.16% quarter-over-quarter from $168.8 million in Q4 2025.

DBV Technologies (DBVT) Common Equity (2015 - 2026) Analysis & Trends

DBV Technologies (DBVT) has 12 years of Common Equity data on file, last reported at $207.9 million in Q1 2026.

  • Common Equity for Q1 2026 came in at $207.9 million, up 7068.97% year-over-year; the trailing twelve-month figure through Mar 2026 was $207.9 million (up 7068.97% YoY), and the FY2025 annual result was $168.8 million, up 516.06% from the prior year.
  • Common Equity grew to $207.9 million in Q1 2026 per DBVT's latest filing, from $168.8 million in the prior quarter.
  • Over five years, Common Equity peaked at $244.4 million in Q2 2022 and troughed at $2.9 million in Q1 2025.
  • A 5-year average of $126.6 million and a median of $140.2 million in 2023 frame the typical range for Common Equity.
  • The sharpest annual moves came in 2025 and 2026: Common Equity tumbled 97.4% in 2025, then soared 7068.97% in 2026.
  • A 5-year view of Common Equity shows it stood at $194.5 million in 2022, then declined by 27.91% to $140.2 million in 2023, then plunged by 80.45% to $27.4 million in 2024, then soared by 516.06% to $168.8 million in 2025, then rose by 23.16% to $207.9 million in 2026.
  • Business Quant data shows DBVT's Common Equity at $207.9 million in Q1 2026, $168.8 million in Q4 2025, and $52.9 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 35.63 Mn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -1.42 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 13.21 Mn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 14.38 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 11.87 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 19.36 Bn
9 Abivax 91.96 Bn 91.96 Bn - -
10 DBV Technologies 6.63 Bn 6.41 Bn -3.90 Mn 207.90 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 207.90 Mn
Dec 31, 2025 168.80 Mn
Sep 30, 2025 52.85 Mn
Jun 30, 2025 86.22 Mn
Mar 31, 2025 2.90 Mn
Dec 31, 2024 27.40 Mn
Sep 30, 2024 54.03 Mn
Jun 30, 2024 79.10 Mn
Mar 31, 2024 111.65 Mn
Dec 31, 2023 140.19 Mn
Sep 30, 2023 143.99 Mn
Jun 30, 2023 164.24 Mn
Mar 31, 2023 179.09 Mn
Dec 31, 2022 194.45 Mn
Sep 30, 2022 212.05 Mn
Jun 30, 2022 244.42 Mn
Mar 31, 2022 82.06 Mn
Dec 31, 2021 99.27 Mn
Sep 30, 2021 116.89 Mn
Jun 30, 2021 143.02 Mn